Date post: | 18-Jul-2016 |
Category: |
Documents |
Upload: | ramya-preethu |
View: | 250 times |
Download: | 12 times |
{
Case Analysis on BIOCON
KIRAN MAZUMDAR SHAW’S ENTREPRENEURIAL DREAM
ByHarish (2t3-08)Sai Sowjanya(2t3-17)J.Ramya (2t3-20) Agasthia (22005)Jyothilakshmi (220-15)Shruthi(220-76)Adithya(220-95)
INTRODUCTION Chairperson and CEO of Biocon Ltd, India’s
largest Biotechnology company. Born on March 23, 1953 Schooling at Bishop Cotton Girls School
and Mount Carmel College, Bangalore B.Sc. in Zoology from Bangalore
University in 1973 Ballarat University in Melbourne,
Australia and qualified as a master brewer.
Awarded honorary doctorates from University of Abertay, Dundee, U.K. (2007), University of Glasgow, U.K. (2008) and Heriot-Watt University, Edinburgh, U.K. (2008)
Trainee brewer in Carlton & United Beverages in 1974
Became India’s first Brew Master
Switch of occupation
Trainee Manager with Biocon Biochemical Limited in Ireland
in 1978
Founded Biocon India in collaboration with Biocon
Biochemical Limited
HER CAREER
Problem Solver Adaptability Personal Responsibility Taker Empirical Optimism Resourcefulness Endurance Insight Humility Awareness Confidence Decisiveness Personable Intelligence Effective Communicator
Prerequisites Of A Successful Entrepreneur
Glass CeilingDEFINITION:A glass ceiling is a political term used to describe "the unseen, yet unbreachable barrier that keeps minorities and women from rising to the upper rungs of the corporate ladder, regardless of their qualifications or achievements.“• The Indian corporate has been largely male dominated, women have been
able to make a mark, but not at the same speed as is seen in the rest of the world.
• In India, only about 25 percent of the business leadership comprises women. Whereas when compared to other countries, women comprise nearly 60 percent of the business leadership.
• Women get so accustomed to their existing job role, which prevents them from reaching the top level.
• Moreover the organization also has a feeling that it is not worth investing in because, they would get married, have a baby and quit.
• The challenges might continue to exist, but there is no doubt that a greater representation of women at the workplace is vital today.
Women like Kiran Mazumdar Shaw (CEO of Biocon, India), Ekta Kapoor, Joint Managing Director and Creative Director of Balaji Telefilms , Swati A. Piramal, Vice Chairperson of Piramal Life Sciences and others of their ilk rub shoulders with men in board rooms and are continuously proving that women are and can be as successful as men.
REASON’S FOR BIOCON’S SUCCESS
• No, that was not only the reason for her success.
• The ability to attract and motivate good people was a key
factor behind Biocon’s success.
• People were hand picked by kiran Mazumdar, they grew with
the company and could not think of working for any other
company.
• Biocon has entrepreneurship ,drive ,and scientific talent in
abundance.
Biocon emerged as an integrated biotechnology enterprise with presence in biopharmaceuticals, enzymes , custom research , clinical research.
Biocon was India’s largest biotechnology company in terms of revenues.
The partnership with Cuban institute CIMAB results to launch the India’s first anti-cancer drug (BIOMAB-EGFR).
CHALLENGES FACED
Personal challenges
Youthful age
Gender
Unfamiliar business
Lack of funds/ assets
Infrastructure
Quality
Managing investors expectations
BIOTECHNOLOGY INDUSTRY IN INDIA Biotechnology has transformed many parts of the chemical
industry, agriculture and medicine. The consumption of biotech products in India was expected to
quadruple within a decade. The human and animal segment of the industry alone was
growing by at least 20%. In 1999, Indian Biotech Industry contributes to 1.5% of the global
biotech industry. In India 800 Companies were operating in all sectors of
biotechnology, but only 25 were working in the modern biotech sectors.
ADVANTAGES OF BIOTECH INDUSTRY IN INDIA
Rich Bio-diversityVaried Species of flora and fauna.Varied climatic zones.Large population and varied demography.Largest agriculture sector.World class information technology. Vast pool of talented and skilled man power. English as the accepted business language. Lower operational costs and technologies.
Increasing Government support for bio technology industry. Government is implementing a national Biotechnology Development Strategy (NBDS) and establishing a national Biotechnology Regulatory Authority (NBRA) .
100% FDI in biotechnology sector. Special tax benefits
India had proved its competency in selected areas of biotechnology such as bioprocess engineering ,skills in gene manipulation of microbes and animal cells, capacity in downstream processing and isolation methods, and its competence in recombinant DNA technology of plants and animals.
Kiran Mzumdar Shaw steered the company through several reinventions, first moving from being an enzymes maker to stains and when prices crashed & chinese competition intensified, she shifted focus to bio-pharma. Now she is focusing on three main businesses-Biocon, Syngene & Clinigene and the company as a major biopharma company.
Kiran Mazumdar Shaw is aware that the real opportunity lies in the US and Western Europe, where hundred of billions of dollar are spent on pharmaceuticals every year. However she also realizes that such markets are difficult to enter as regulatory charges are high and there are many large competitors, much larger than Biocon.
PERSONALITYHigh self esteem
Loves and believes in herself Tradition and culture
High on conscientiousness Reliable Responsible Organized Dependable
High on agreeableness Warm with employees, stakeholders Trust
High on emotional stability Positive emotional stability
Transformational LeadershipBehavior: Count on every one to give best. Transform teams even under unfavorable conditions Serve as role model How this works: By pursuing innovation with strategic actions. Motivate group by strengthening team optimism and commitment also enthusiasm.
THANK YOU